Key organizational relationships within the DoD CBDP are portrayed in the figure below. The CBDP management structure applies to the processes (1) to provide policy guidance, (2) to conduct planning, programming, budgeting, and execution of CBRN defense research, development and acquisition, (3) to establish military requirements for CBRN defense, (4) to test and evaluate CBRN defense programs, (5) to manage chemical and biological defense science and technology programs, (6) for program analysis and integration, and (7) for program oversight.
Under the Implementation Plan, the Defense Threat Reduction Agency (DTRA) serves two key
roles in support of the DoD CBDP-Funds Manager and Joint Science and Technology Manager.
These roles are filled by DTRA's Chemical and Biological Defense Directorate, DTRA(CB), also designated
as the Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD). The
JSTO-CBD provides funds management functions under the oversight of the ATSD(NCB). JSTO-CBD
also manages and integrates chemical and biological defense science and technology base (S&T) programs.
S&T management responsibilities include the development and integration of S&T programs in response
to ATSD(NCB) and JRO-CBRN Defense guidance. The JSTO-CBD provides the necessary programming,
planning, and budgeting documentation for chemical and biological defense S&T programs. The JSTO-CBD
works with the JPEO-CBD to ensure effective transition of S&T efforts to advanced development.
For medical products requiring approval by the Food and Drug Administration (FDA), JSTO-CBD works
with JPEO-CBD to support the transition of research programs into clinical trials. Other JSTO-CBD
responsibilities include providing a DoD CBRN defense S&T liaison with various organizations (to
include DARPA, industry, academia, and other government agencies), providing support for DoD CBRN
defense S&T international programs, and providing management and integration of CBRN defense ACTDs.
Since establishment of the Implementation Plan in April 2003, a significant portion of JSTO's intramural (i.e., research conducted at Service labs) medical CB S&T programs continue to be assigned to U.S. Army Medical Research and Materiel Command (USAMRMC) laboratories for execution. The majority of JSTO's intramural medical biological defense research is conducted at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) with smaller portions being conducted at the Walter Reed Army Institute of Research (WRAIR) and at the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD). Similarly, the majority of JSTO's core medical chemical defense research is conducted at USAMRICD while a smaller portion is conducted at WRAIR.
A Memorandum of Agreement (MOA) between DTRA and USAMRMC defines and clarifies the relationship between the two organizations regarding execution of medical CB S&T programs assigned to USAMRMC by JSTO-CBD. The CB Defense Partnership Support Directorate, a staff office of the Commanding General, USAMRMC, is responsible for oversight of medical CB S&T research being executed by USAMRMC laboratories and for coordinating among USAMRMC Headquarters, USAMRMC Laboratory Command staff, and JSTO on the execution of medical CB S&T programs at USAMRMC laboratories. The Partnership Support Directorate also provides technical support to JSTO in its annual medical CB S&T program build process and analytical and technical support to JSTO in administering, executing and reporting on medical CB S&T research programs assigned by Congress.